382 filings
Page 7 of 20
8-K
4tixtqo nm
6 Nov 14
Spectrum Pharmaceuticals Reports Strong Product Sales for the Third Quarter 2014; Sales of $47.9 Million up 15.6% Over Last Year
12:00am
8-K
yyzik50wt as2
7 Aug 14
Launches Fifth Product and Moves Closer to a Decision on a Potential Blockbuster
12:00am
8-K
rc5nqz n9vk5z
3 Jul 14
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
12:00am
8-K
h5avzerqwn91rm xpsv
27 Jun 14
Submission of Matters to a Vote of Security Holders
12:00am
8-K
i7c1f
26 Jun 14
First Amendment to License Agreement
12:00am
8-K
5egwuw
12 May 14
Departure of Directors or Certain Officers
12:00am
8-K
ig1dqrzmc32 jbnqe
8 May 14
Spectrum Pharmaceuticals Reports Financial Results for First Quarter 2014
12:00am
8-K
duli2dsrw
17 Apr 14
Departure of Directors or Certain Officers
12:00am
8-K
dov4ap qgmnlk
11 Apr 14
Entry into a Material Definitive Agreement
12:00am
8-K
1ahipm
10 Apr 14
Changes in Registrant's Certifying Accountant
12:00am
8-K
67m 5x6kqb
31 Mar 14
Departure of Directors or Certain Officers
12:00am
8-K
3faxu35axm 59xdh
21 Mar 14
Changes in Registrant's Certifying Accountant
12:00am
8-K
44nr q710
6 Mar 14
Spectrum Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results
12:00am
8-K
do7u02gg
6 Feb 14
Spectrum Pharmaceuticals Announces FDA’s Acceptance of NDA Filing for Beleodaq™ (belinostat) for Injection, a novel pan-HDAC inhibitor
12:00am
8-K
xcfsmruq8wj6az67np
13 Jan 14
Departure of Directors or Certain Officers
12:00am
8-K
tiv8aphkamo uphik
23 Dec 13
Entry into a Material Definitive Agreement
12:00am
8-K
aom2fu30rkh0i5 9yfje
19 Dec 13
Financial Statements and Exhibits
12:00am
8-K
xkinpgcu o3su
6 Dec 13
Departure of Directors or Certain Officers
12:00am
8-K/A
z59e9h
18 Nov 13
Amendment to License and Collaboration Agreement
12:00am
8-K
ksrpmgk fcpcx3o1vj6
12 Nov 13
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
12:00am